ARTICLE | Clinical News
CpG 7909: Began Phase I study
April 19, 1999 7:00 AM UTC
CpG ImmunoPharmaceuticals Inc., Wellesley, Mass. Product: CpG 7909 Business: Infectious diseases Therapeutic category: Adjuvant, Immune stimulation Target: Immune cells Description: CpG-containing ol...